CKD prevalence varies across the European general population

Katharina Brück, Vianda S. Stel, Giovanni Gambaro, Stein Hallan, Henry Völzke, Johan Ärnlöv, Mika Kastarinen, Idris Guessous, José Vinhas, Bénédicte Stengel, Hermann Brenner, Jerzy Chudek, Solfrid Romundstad, Charles Tomson, Alfonso Otero Gonzalez, Aminu K. Bello, Jean Ferrieres, Luigi Palmieri, Gemma Browne, Vincenzo CapuanoWim Van Biesen, Carmine Zoccali, Ron Gansevoort, Gerjan Navis, Dietrich Rothenbacher, Pietro Manuel Ferraro, Dorothea Nitsch, Christoph Wanner, Kitty J. Jager

Research output: Contribution to journalArticle

233 Citations (Scopus)

Abstract

CKD prevalence estimation is central to CKD management and prevention planning at the population level. This study estimated CKD prevalence in the European adult general population and investigated international variation in CKD prevalence by age, sex, and presence of diabetes, hypertension, and obesity. We collected data from 19 general-population studies from 13 European countries. CKD stages 1-5 was defined as eGFR<60 ml/min per 1.73 m2, as calculated by the CKD-Epidemiology Collaboration equation, or albuminuria >30 mg/g, and CKD stages 3-5 was defined as eGFR<60 ml/min per 1.73 m2. CKD prevalence was age- and sex-standardized to the population of the 27 Member States of the European Union (EU27). We found considerable differences in both CKD stages 1-5 and CKD stages 3-5 prevalence across European study populations. The adjusted CKD stages 1-5 prevalence varied between 3.31% (95% confidence interval [95% CI], 3.30% to 3.33%) inNorway and 17.3% (95% CI, 16.5% to 18.1%) in northeastGermany. The adjusted CKDstages 3-5 prevalence varied between 1.0% (95% CI, 0.7% to 1.3%) in central Italy and 5.9% (95% CI, 5.2% to 6.6%) in northeast Germany. The variation in CKD prevalence stratified by diabetes, hypertension, and obesity status followed the same pattern as the overall prevalence. In conclusion, this large-scale attempt to carefully characterize CKD prevalence in Europe identified substantial variation in CKD prevalence that appears to be due to factors other than the prevalence of diabetes, hypertension, and obesity.
Original languageEnglish
Pages (from-to)2135-2147
Number of pages13
JournalJOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume27
DOIs
Publication statusPublished - 2016

Keywords

  • Nephrology
  • chronic kidney disease
  • clinical epidemiology
  • creatinine

Fingerprint

Dive into the research topics of 'CKD prevalence varies across the European general population'. Together they form a unique fingerprint.

Cite this